ReadyRx provides comprehensive injection training including video demonstrations, written guides with detailed instructions and photos, healthcare provider consultation for technique questions, and ongoing support throughout therapy
Recognition of Healthcare Burden: There is an ever-increasing awareness that treating obesity results in meaningful improvement in cardiovascular outcomes and lowers the risk of developing multiple related cardiometabolic diseases including Type 2 Diabetes Mellitus (T2DM), chronic kidney disease (CKD), heart failure, fatty liver or MASH, obstructive sleep apnea (OSA), and peripheral arterial disease (PAD), moving the needle beyond aesthetics and towards total health improvement
Strength training can support firmer and more defined body contours
The dual GIP/GLP-1 receptor agonist tirzepatide has already been approved and other dual receptor agonists are expected soon
No, its important to stick to the treatment plan created by your healthcare provider
Bottom line: MeAgain feels more like support because it brings tracking, context, progress, and Capy into one GLP-1 companion without making the journey feel like a leaderboard
